Colorectal cancer (CRC) has become the leading cause of cancer-related deaths in people under 50—a trend driven in part by late-stage diagnoses, where survival rates fall to just 14%. Yet when CRC is detected early, survival exceeds 90%, making timely screening one of the most powerful tools we have.

In recent years, national guidelines have lowered the recommended CRC screening age from 50 to 45 for average‑risk adults. But with younger populations increasingly affected, is that enough? Should screening begin even earlier, or should benefits be expanded to reach more at‑risk individuals?

Our new white paper explores these questions—and more—to help health benefits brokers guide employers toward smarter, more proactive screening strategies.

Complete the form below to download our white paper.